Q4 2025 Marico Ltd Earnings Call Transcript
Key Points
- Marico Ltd (BOM:531642) achieved double-digit consolidated revenue growth for FY25, supported by improving volume growth in India and broad-based growth in international markets.
- The company reported robust value growth of 44% year-over-year in Q4 for its food segment, surpassing the INR 900 crore mark in annual revenues.
- Premium Personal Care sustained strong momentum, with the digital-first portfolio exiting FY25 at a INR 750 crore ARR, exceeding expectations.
- International business maintained double-digit constant currency growth, with Bangladesh and MENA regions showing resilience and consistent performance.
- Marico Ltd (BOM:531642) has significantly improved the profitability of its foods and premium personal care portfolios, contributing to a more resilient revenue mix.
- Margins were under pressure due to input cost inflation, particularly in copra prices, which are expected to remain high in the short term.
- Parachute had a muted quarter due to consumption titration during hyperinflationary cycles, with only low single-digit volume growth.
- General trade remains sluggish, and efforts are being made to revive it through Project SETU, indicating challenges in traditional distribution channels.
- The company faces competitive pressures in the coconut oil segment, with smaller players and branded competition impacting market dynamics.
- Volume growth in the Saffola edible oil segment is impacted by sharp price hikes, with expectations of steady volumes contingent on stable vegetable oil prices.
Ladies and gentlemen, good day and welcome to Marico Limited Q4 FY25 Earnings Conference Call.
We have with us the senior management of Marico represented by Mr. Saugata Gupta, MD and CEO; and Mr. Pawan Agrawal, CFO.
(Operator Instructions)
Please note that this conference is being recorded. Before we get started, I would like to remind you that the Q&A session is only for institutional investors and analysts and therefore, if there is anybody else who is not an institutional investor or analyst but would like to ask questions, please directly reach out to Marico's Investor Relations team.
I now hand the conference over to Mr. Saugata Gupta for his opening comments.
Thank you and over to you, sir.
Yes. Hi. Good evening to all those who have joined the call, and I hope all of you are doing well. With FY25, having come to a close, I would like to begin by sharing a quick overview on the operating environment during the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
